CENTURY THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.88 USD | -8.57% |
|
-6.80% | -13.25% |
| Apr. 12 | Piper Sandler Adjusts Price Target on Century Therapeutics to $9 From $10, Maintains Overweight Rating | MT |
| Apr. 11 | Syncona agrees to sell stake in investee company for GBP7.4 million | AN |
Chart calendar Century Therapeutics, Inc.
21b.wktc1FKb7aw2hYB8q1609NYR6qVlKlmlVDu5KTK04gk.kCwdsGLa3u5ezfQmkybtn6dzstAzSTLRPE7aQlriqk70AxS9JsOY4mC96w~4d2a62bb8a605ffadb7ec3434f5a825d
Upcoming events on Century Therapeutics, Inc.
Past events on Century Therapeutics, Inc.
| 2024-04-10 12:00 pm | American Association for Cancer Research Meeting - Abstract No - 6802 |
| 2024-04-09 12:00 pm | American Association for Cancer Research Meeting - Abstract No - 4009 |
| 2024-04-08 04:30 pm | American Association for Cancer Research Meeting - Abstract No - 3613 |
| 2024-04-08 12:00 pm | American Association for Cancer Research Meeting - Abstract No - 1916 |
| 2024-04-08 12:00 pm | American Association for Cancer Research Meeting - Abstract No - 1320 |
| 2024-04-07 04:30 pm | American Association for Cancer Research Meeting - Abstract No - 36 |
| 2024-03-26 01:30 pm | H.C. Wainwright Cell Therapy Virtual Conference |
| 2024-03-14 07:30 am | Q4 2023 Earnings Release |
| 2024-02-08 02:30 pm | Guggenheim Healthcare Talks Biotechnology Conference |
| 2023-12-11 10:30 am | CNTY-101 Phase 1 Trial Results Call |
| 2023-12-09 08:30 pm | American Society of Hematology Meeting - Abstract No:1654 |
| 2023-11-28 10:00 am | Piper Sandler Healthcare Conference - Fireside Chat |
| 2023-11-09 07:01 am | Q3 2023 Earnings Release |
| 2023-10-10 | Cell & Gene Meeting on the Mesa Conference |
| 2023-10-03 09:00 am | Chardan Genetic Medicines Conference - Fireside Chat |
| 2023-08-09 07:30 am | Q2 2023 Earnings Release |
| 2023-06-27 09:00 am | Annual General Meeting |
| 2023-05-11 07:30 am | Q1 2023 Earnings Release |
| 2023-04-24 10:30 am | Chardan Genetic Medicines & Cell Therapy Manufacturing Virtual Summit |
| 2023-04-17 01:30 pm | American Association for Cancer Research Meeting - Abstract Number: 2914 |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 5,20 6,96 -25.34% | 2,24 3,82 -41.54% | 1,02 |
|
EBITDA Million USD | Released Forecast Spread | -91,1 -90,1 -1.11% | -125 -134 6.46% | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -94,9 -93,0 -2.07% | -134 -136 1.3% | -147 -133 -9.97% | -141 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -95,8 -94,2 -1.64% | -131 -133 1.87% | -135 -124 -8.96% | -137 |
|
Net income Million USD | Released Forecast Spread | -95,8 -93,3 -2.76% | -131 -134 2.12% | -137 -126 -8.33% | -137 |
|
EPS USD | Released Forecast Spread | -2,96 -3,21 7.91% | -2,27 -2,32 2.09% | -2,30 -2,09 -9.9% | -2,05 |
| Announcement Date | 17/03/22 | 16/03/23 | 14/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 1,06 6,67 -84.13% | 1,40 1,34 4.33% | 2,22 1,24 79.77% | 0,52 2,32 -77.53% | 1,72 1,47 17.01% | 0,10 1,56 -93.66% | 0,15 1,11 -86.61% | 0,27 1,89 -85.85% | 0,23 | 0,23 | 0,35 | 0,35 | 1,00 |
|
EBITDA Million USD | Released Forecast Spread | -26,9 -26,7 -0.94% | -27,6 -25,3 -9.34% | ||||||||||||
|
EBIT Million USD | Released Forecast Spread | -28,0 -26,9 -4.03% | -27,4 -30,7 10.5% | -31,4 -29,2 -7.32% | -31,7 -34,7 8.61% | -33,3 -35,3 5.74% | -32,1 -31,0 -3.53% | -30,9 -32,6 5.37% | -35,6 -32,3 -10.28% | -43,8 -35,2 -24.37% | -32,4 | -34,3 | -35,7 | -38,1 | -37,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -28,9 -26,9 -7.23% | -37,5 -30,8 -21.89% | -31,0 -28,8 -7.71% | -30,7 -33,4 7.91% | -31,7 -34,3 7.85% | -30,1 -31,5 4.66% | -32,3 -32,3 -0.03% | -32,1 -31,3 -2.59% | -40,3 -34,1 -18.09% | -31,3 | -33,4 | -34,9 | -37,4 | -36,0 |
|
Net income Million USD | Released Forecast Spread | -28,2 -26,2 -7.71% | -37,5 -25,9 -44.73% | -31,0 -29,0 -6.73% | -30,7 -34,3 10.23% | -31,7 -34,8 8.91% | -31,3 -30,4 -2.71% | -33,3 -31,8 -4.71% | -32,7 -31,6 -3.69% | -39,4 -32,8 -20.26% | -31,3 | -33,4 | -34,9 | -37,4 | -36,0 |
|
EPS USD | Released Forecast Spread | -0,24 -0,48 49.7% | -0,66 -0,46 -44.1% | -0,54 -0,50 -8% | -0,53 -0,59 9.44% | -0,55 -0,59 7.18% | -0,53 -0,52 -1.27% | -0,56 -0,54 -3.28% | -0,55 -0,51 -7.24% | -0,66 -0,55 -19.07% | -0,51 | -0,52 | -0,52 | -0,55 | -0,47 |
| Announcement Date | 17/03/22 | 16/05/22 | 11/08/22 | 10/11/22 | 16/03/23 | 11/05/23 | 09/08/23 | 09/11/23 | 14/03/24 | - | - | - | - | - |
| Today 04:05 pm | QIAGEN N.V.: Q1 2024 Earnings Release |
| 2024-04-29 | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-05-01 06:30 am | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| 2024-05-01 06:30 am | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| 2024-05-01 07:00 am | ALKERMES PLC: Q1 2024 Earnings Release |
| 2024-05-01 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
Past sector events for Century Therapeutics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- IPSC Stock
- Calendar Century Therapeutics, Inc.
